Corti A, Barbanti E, Tempest P R, Carr F J, Marcucci F
Molecular Immunology and Biochemistry Unit, Tecnogen SCpA, Milan, Italy.
J Mol Biol. 1994 Jan 7;235(1):53-60. doi: 10.1016/s0022-2836(05)80012-9.
The contribution of framework regions (FRs) of antibody-variable domains to idiotype expression was studied by examining the interaction of various "humanized" versions of a mouse anti-TNF alpha monoclonal antibody (mAb78) with polyclonal and two monoclonal antibodies (mAb1G3 and mAb9F1), generated against the mAb78 idiotype. Humanized mAb78, bearing human constant domains and mouse complementarity-determining regions (CDRs) inserted with human FRs, was found to be five to sevenfold less reactive than mAb78 with polyclonal anti-idiotype antibodies and 200 to 300-fold less active in neutralizing TNF alpha. The substitution of heavy-chain FRs residues of the humanized antibody with original mouse residues 28 to 30, 48 to 49, 67 to 68, 70 to 71, 78, 80 and 82 progressively restored the immunoreactivity with polyclonal immunoglobulin Gs to the level of a version having mouse heavy chain and human light chain FRs, and increased 10 to 20-fold the TNF alpha neutralizing activity. This suggests that at least some of these residues are critical for TNF alpha binding as well as for the expression of idiotopes that are strongly immunogenic in syngeneic animals. All antibody versions with either human or mouse FRs were able to bind to various extents mAb1G3, a gamma-type anti-Id antibody that inhibits mAb78/TNF alpha interaction by paratope blockade. At variance, only the antibody versions containing mouse FRs were able to bind mAb9F1, an alpha-type anti-Id antibody unable to block the access of TNF alpha to mAb78 paratopes. Substitution of heavy chain FR residues 28 to 30 markedly decreased the binding of mAb1G3 (100 to 1000-fold). This suggests that these antibodies recognize CDR and FR idiotopes, respectively, that can be drastically modified by changes in the FRs. In conclusion, the results suggest that CDRs as well as FRs markedly contribute to antibody Id expression. Although strongly immunogenic idiotopes are probably located within the CDRs, the results also suggest that some FR residues are critically involved in shaping antibody Id diversity by affecting the structure of CDR-related idiotopes.
通过检测小鼠抗TNFα单克隆抗体(mAb78)的各种“人源化”版本与针对mAb78独特型产生的多克隆抗体及两种单克隆抗体(mAb1G3和mAb9F1)之间的相互作用,研究了抗体可变区框架区(FRs)对独特型表达的贡献。发现携带人恒定区且插入人FRs的人源化mAb78与多克隆抗独特型抗体的反应性比mAb78低5至7倍,在中和TNFα方面的活性比mAb78低200至300倍。将人源化抗体重链FRs残基替换为原始小鼠残基28至30、48至49、67至68、70至71、78、80和82,可逐步将与多克隆免疫球蛋白Gs的免疫反应性恢复至具有小鼠重链和人轻链FRs的版本的水平,并使TNFα中和活性提高10至20倍。这表明这些残基中至少有一些对于TNFα结合以及在同基因动物中具有强免疫原性的独特型的表达至关重要。所有具有人或小鼠FRs的抗体版本都能不同程度地结合mAb1G3,mAb1G3是一种γ型抗独特型抗体,通过互补位阻断抑制mAb78/TNFα相互作用。与之不同的是,只有包含小鼠FRs的抗体版本能够结合mAb9F1,mAb9F1是一种α型抗独特型抗体,无法阻断TNFα进入mAb78的互补位。替换重链FR残基28至30可显著降低mAb1G3的结合(100至1000倍)。这表明这些抗体分别识别CDR和FR独特型,而FRs的变化可对其进行显著修饰。总之,结果表明CDR以及FR对抗体独特型表达有显著贡献。尽管强免疫原性独特型可能位于CDR内,但结果也表明一些FR残基通过影响与CDR相关独特型的结构,在塑造抗体独特型多样性方面起着关键作用。